Human medicines European public assessment report (EPAR): Lutathera, lutetium (177Lu) oxodotreotide, Neuroendocrine Tumors, Date of authorisation: 26/09/2017, Revision: 2, Status: Authorised

Case Medical Research ◽

10.31525/cmr-f22274 ◽

2019 ◽

Author(s):

Keyword(s):

Neuroendocrine Tumors ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Sutent, sunitinib, Gastrointestinal Stromal Tumors,Carcinoma, Renal Cell,Neuroendocrine Tumors, Date of authorisation: 19/07/2006, Revision: 36, Status: Authorised

Case Medical Research ◽

10.31525/cmr-8cd85e ◽

2019 ◽

Author(s):

Keyword(s):

Neuroendocrine Tumors ◽

Renal Cell ◽

Gastrointestinal Stromal Tumors ◽

Assessment Report ◽

Stromal Tumors ◽

European Public ◽

European Public Assessment Report ◽

Carcinoma Renal Cell

Download Full-text

Human medicines European public assessment report (EPAR): Sutent, sunitinib, Gastrointestinal Stromal Tumors,Carcinoma, Renal Cell,Neuroendocrine Tumors, Date of authorisation: 19/07/2006, Revision: 36, Status: Authorised

Case Medical Research ◽

10.31525/cmr-8d794b ◽

2019 ◽

Author(s):

Keyword(s):

Neuroendocrine Tumors ◽

Renal Cell ◽

Gastrointestinal Stromal Tumors ◽

Assessment Report ◽

Stromal Tumors ◽

European Public ◽

European Public Assessment Report ◽

Carcinoma Renal Cell

Download Full-text

Human medicines European public assessment report (EPAR): Xermelo, telotristat ethyl, Carcinoid Tumor,Neuroendocrine Tumors, Date of authorisation: 17/09/2017, Revision: 6, Status: Authorised

Case Medical Research ◽

10.31525/cmr-babd57 ◽

2019 ◽

Author(s):

Keyword(s):

Carcinoid Tumor ◽

Neuroendocrine Tumors ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): SomaKit TOC, edotreotide, Neuroendocrine Tumors,Radionuclide Imaging, Date of authorisation: 08/12/2016, Revision: 3, Status: Authorised

Case Medical Research ◽

10.31525/cmr-b9c421 ◽

2019 ◽

Author(s):

Keyword(s):

Neuroendocrine Tumors ◽

Radionuclide Imaging ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Xermelo, telotristat ethyl, Carcinoid Tumor,Neuroendocrine Tumors, Date of authorisation: 17/09/2017, Revision: 4, Status: Authorised

Case Medical Research ◽

10.31525/cmr-bb17ba ◽

2019 ◽

Author(s):

Keyword(s):

Carcinoid Tumor ◽

Neuroendocrine Tumors ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Bavencio, avelumab, Neuroendocrine Tumors, Date of authorisation: 18/09/2017, Revision: 4, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1618f7f ◽

2019 ◽

Author(s):

Keyword(s):

Neuroendocrine Tumors ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): SomaKit TOC, edotreotide, Neuroendocrine Tumors,Radionuclide Imaging, Date of authorisation: 08/12/2016, Revision: 3, Status: Authorised

Case Medical Research ◽

10.31525/cmr-b969bd ◽

2019 ◽

Author(s):

Keyword(s):

Neuroendocrine Tumors ◽

Radionuclide Imaging ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Fabrazyme, agalsidase beta, Fabry Disease, Date of authorisation: 03/08/2001, Revision: 26, Status: Authorised

Case Medical Research ◽

10.31525/cmr-19715f1 ◽

2019 ◽

Author(s):

Keyword(s):

Fabry Disease ◽

Agalsidase Beta ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Controloc Control, pantoprazole, Gastroesophageal Reflux, Date of authorisation: 11/06/2009, Revision: 11, Status: Authorised

Case Medical Research ◽

10.31525/cmr-193042d ◽

2019 ◽

Author(s):

Keyword(s):

Gastroesophageal Reflux ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text